Fate Therapeutics (FATE) Assets (2016 - 2025)
Historic Assets for Fate Therapeutics (FATE) over the last 14 years, with Q3 2025 value amounting to $343.7 million.
- Fate Therapeutics' Assets fell 3056.73% to $343.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $343.7 million, marking a year-over-year decrease of 3056.73%. This contributed to the annual value of $440.7 million for FY2024, which is 1294.37% down from last year.
- Per Fate Therapeutics' latest filing, its Assets stood at $343.7 million for Q3 2025, which was down 3056.73% from $371.6 million recorded in Q2 2025.
- In the past 5 years, Fate Therapeutics' Assets registered a high of $1.0 billion during Q1 2021, and its lowest value of $343.7 million during Q3 2025.
- Over the past 5 years, Fate Therapeutics' median Assets value was $584.8 million (recorded in 2023), while the average stood at $658.0 million.
- As far as peak fluctuations go, Fate Therapeutics' Assets surged by 22494.45% in 2021, and later plummeted by 3056.73% in 2025.
- Quarter analysis of 5 years shows Fate Therapeutics' Assets stood at $921.5 million in 2021, then fell by 23.43% to $705.6 million in 2022, then dropped by 28.25% to $506.2 million in 2023, then fell by 12.94% to $440.7 million in 2024, then dropped by 22.02% to $343.7 million in 2025.
- Its Assets was $343.7 million in Q3 2025, compared to $371.6 million in Q2 2025 and $398.7 million in Q1 2025.